← Scroll for more →
aTYR PHARMA Inc (ATYR)
Biological Products, (No Diagnostic Substances)
Latest Price
$0.30
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.50
P/B Ratio
0.61
Institutional Ownership
39.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 8.51M | $5.0M | 8.68% | -2.00M | 2026-06-30 |
| Vanguard Capital Management LLC | 3.81M | $2.0M | 3.88% | -4.0K | 2026-06-30 |
| Gsa Capital Partners LLP | 3.45M | $2.0M | 3.52% | +1.77M | 2026-06-30 |
| AQR Capital Management LLC | 2.61M | $1.0M | 2.66% | +2.11M | 2026-06-30 |
| FMR LLC | 2.47M | $1.0M | 2.52% | -12.24M | 2026-06-30 |
| Jane Street Group, LLC | 1.91M | $1.0M | 1.95% | +1.41M | 2026-06-30 |
| BlackRock, Inc. | 1.83M | $1.0M | 1.86% | -4.62M | 2026-06-30 |
| Kalehua Capital Management LLC | 1.79M | $1.0M | 1.82% | -- | 2026-06-30 |
| Citadel Advisors LLC | 1.55M | -- | 1.58% | +1.34M | 2026-06-30 |
| UBS Group AG | 1.53M | -- | 1.56% | -2.34M | 2026-06-30 |